Enhanced Bioavailability and Systemic Reach Injecting BPC-157 directly into subcutaneous tissue ensures high bioavailability , avoiding enzymatic degradation
Duration is usually time-limited, with frequent reassessment of benefits, side effects, and quality of life
TRIUMPH 1, 2 & 3 are all 80-week trials so they will show EVEN more weight loss which is almost hard to fathom
The method outlined above is almost identical to the method described in section Radiometric Detection of Lipoprotein Lipase Activity Using Triolein, ApoC-II, and Angiopoietin-Like 4, therefore, here we only detail the steps that differ from the above protocol
The 8mg dose produced 21.1% average weight loss, which represents 88% of the maximum doses efficacy with meaningfully better tolerability